Right Column

T2-00001: Training Stem Cell Researchers at the Chemistry-Biology Interface

Application Number:  T2-00001

Proposal Abstract as Submitted by Applicant

We will exploit the unique strengths of The Scripps Research Institute (TSRI) in Chemistry and Biology to provide an interdisciplinary stem cell training program that incorporates teaching and research in chemistry, functional genomics, and molecular genetics. The goal of this proposal is to train scientists for future careers in basic or applied research in the field of stem cell biology. In particular, the aim of this program is to train coworkers who can work at the interface of chemistry and biology in order to more effectively apply chemical tools and approaches to basic research and the development of new therapeutic approaches in regenerative medicine. This requires a training program that brings together graduate students and postdoctoral fellows from the biology and chemistry disciplines in order to (1) educate them in the basic biology, methods, and applications in embryonic and adult stem cell biology; (2) cross train them in the principles and approaches that chemists and biologists apply to biological problems; (3) foster research collaborations between chemists and biologists in the stem cell field; and (4) stimulate an awareness of the problems and ethical issues associated with basic and applied stem cell research. This training program, although relatively small in size, will benefit from close interactions with the broader San Diego stem cell community (UCSD, Salk, Burnham) including collaborative research projects and joint seminar programs, classes, and workshops. We are requesting a Type II program with support for 10 trainees to be educated at TSRI.

Benefit of this Program to California

This program will benefit the people and the state of California by providing high-quality training in the scientific, clinical, social, and ethical aspects of stem cell research to the scientists and clinicians who will develop and apply future therapies in this rapidly emerging field.